HUM vs SPRO
Humana Inc (HUM) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the HUM and SPRO stock pages for the full models.
Not investment advice.